| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| isosorbide dinitrate | Tablet, uncoated | 5 mg | Anticipated | Available | Manufacturing | 21/02/2025 |
| ciprofloxacin hydrochloride | Tablet, film coated | 277.5 mg | Anticipated | Available | Manufacturing | 21/02/2025 |
| ropinirole hydrochloride | Tablet, film coated | .57 mg | Resolved | Available | Manufacturing | 21/02/2025 |
| trihexyphenidyl (benzhexol) hydrochloride | Tablet, uncoated | 2 mg | Resolved | Available | Unexpected increase in consumer demand | 21/02/2025 |
| risperidone | Tablet, film coated | 3 mg | Current | Unavailable | Manufacturing | 21/02/2025 |
| risperidone | Tablet, film coated | 1 mg | Current | Unavailable | Manufacturing | 21/02/2025 |
| risperidone | Tablet, film coated | 2 mg | Current | Unavailable | Manufacturing | 21/02/2025 |
| letrozole | Tablet, film coated | 2.5 mg | Anticipated | Available | Manufacturing | 21/02/2025 |
| levetiracetam | Tablet, film coated | 1000 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 21/02/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | 1 mg | Anticipated | Available | Manufacturing | 21/02/2025 |
| olanzapine | Tablet, orally disintegrating | 5 mg | Current | Limited Availability | Manufacturing | 21/02/2025 |
| galantamine hydrobromide | Capsule, modified release | 10.252 mg | Current | Unavailable | Manufacturing | 21/02/2025 |
| galantamine hydrobromide | Capsule, modified release | 20.504 mg | Current | Unavailable | Manufacturing | 21/02/2025 |
| montelukast sodium | Tablet, chewable | 5.2 mg | Anticipated | Available | Unexpected increase in consumer demand | 21/02/2025 |
| sildenafil citrate | Tablet, film coated | 28.1 mg | Anticipated | Available | Manufacturing | 21/02/2025 |
| azithromycin dihydrate | Tablet, film coated | 524.05 mg | Current | Unavailable | Manufacturing | 21/02/2025 |
| quetiapine fumarate | Tablet, modified release | 460.52 mg | Resolved | Available | Manufacturing | 21/02/2025 |
| quetiapine fumarate | Tablet, modified release | 57.565 mg | Anticipated | Available | Unexpected increase in consumer demand | 21/02/2025 |
| metformin hydrochloride | Tablet, modified release | 1000 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 21/02/2025 |
| dutasteride | Capsule, soft | 500 microgram | Anticipated | Available | Manufacturing | 21/02/2025 |
| linezolid | Tablet, film coated | 600 mg | Anticipated | Available | Manufacturing | 21/02/2025 |
| ezetimibe | Tablet | 10 mg | Resolved | Available | Manufacturing | 21/02/2025 |
| ezetimibe | Tablet, uncoated | 10 mg | Current | Unavailable | Unexpected increase in consumer demand | 21/02/2025 |
| ezetimibe | Tablet, uncoated | 10 mg | Current | Unavailable | Manufacturing | 21/02/2025 |
| risperidone | Tablet, film coated | 1 mg | Current | Unavailable | Manufacturing | 21/02/2025 |
| risperidone | Tablet, film coated | 2 mg | Current | Unavailable | Manufacturing | 21/02/2025 |
| risperidone | Tablet, film coated | 3 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 21/02/2025 |
| risperidone | Tablet, film coated | 4 mg | Current | Unavailable | Manufacturing | 21/02/2025 |
| latanoprost~timolol maleate | Eye Drops, solution | .05 mg/mL~6.83 mg/mL | Current | Unavailable | Manufacturing | 21/02/2025 |
| prasugrel | Tablet, film coated | 5 mg | Current | Unavailable | Manufacturing | 21/02/2025 |
| dosulepin (dothiepin) hydrochloride | Capsule, hard | 25 mg | Anticipated | Available | Manufacturing | 21/02/2025 |
| azithromycin dihydrate | Tablet, film coated | 524 mg | Current | Unavailable | Unexpected increase in consumer demand | 21/02/2025 |
| gramicidin~framycetin sulfate~dexamethasone | Ear Drops | .05 mg/mL~5 mg/mL~.5 mg/mL | Anticipated | Available | Manufacturing | 21/02/2025 |
| estradiol~dydrogesterone | Tablet, film coated | 2 mg~10 mg | Current | Unavailable | Manufacturing | 21/02/2025 |
| ciprofloxacin hydrochloride | Tablet, film coated | 873.32 mg | Resolved | Available | Manufacturing | 21/02/2025 |
| flucloxacillin | Injection, powder for | 1 g | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 21/02/2025 |
| famotidine | Tablet, film coated | 20 mg | Resolved | Available | Manufacturing | 21/02/2025 |
| mirtazapine | Tablet, film coated | 30 mg | Anticipated | Available | Manufacturing | 21/02/2025 |
| methylphenidate hydrochloride | Tablet, modified release | 27 mg | Current | Limited Availability | Manufacturing | 20/02/2025 |
| amisulpride | Tablet | 100 mg | Current | Unavailable | Manufacturing | 20/02/2025 |
| azithromycin dihydrate | Tablet, film coated | 524.1 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 20/02/2025 |
| mycophenolate mofetil | Tablet, film coated | 500 mg | Current | Unavailable | Manufacturing | 20/02/2025 |
| mirtazapine | Tablet, film coated | 45 mg | Current | Unavailable | Manufacturing | 20/02/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | 1 mg | Current | Limited Availability | Manufacturing | 20/02/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | .25 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 20/02/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | .125 mg | Anticipated | Available | Manufacturing | 20/02/2025 |
| amlodipine besilate~hydrochlorothiazide~olmesartan medoxomil | Tablet | 6.944 mg~25 mg~40 mg | Current | Limited Availability | Manufacturing | 20/02/2025 |
| nicorandil | Tablet | 10 mg | Current | Limited Availability | Manufacturing | 20/02/2025 |
| rizatriptan benzoate | Wafer | 14.53 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 20/02/2025 |
| tobramycin | Injection, solution | 40 mg/mL | Current | Unavailable | Unexpected increase in consumer demand | 20/02/2025 |
| esomeprazole | Capsule, enteric | 20 mg | Resolved | Available | Manufacturing | 20/02/2025 |
| anastrozole | Tablet, film coated | 1 mg | Current | Unavailable | Manufacturing | 20/02/2025 |
| hydrocortisone | Tablet, uncoated | 20 mg | Current | Limited Availability | Manufacturing | 20/02/2025 |
| mesalazine | Tablet, enteric coated | 250 mg | Current | Unavailable | Manufacturing | 20/02/2025 |
| celecoxib | Capsule, hard | 100 mg | Current | Unavailable | Manufacturing | 20/02/2025 |
| acamprosate calcium | Tablet, enteric coated | 333 mg | Anticipated | Available | Unexpected increase in consumer demand | 20/02/2025 |
| mefenamic acid | Capsule, hard | 250 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 20/02/2025 |
| buprenorphine | Patch, dermal | 30 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 20/02/2025 |
| deferasirox | Tablet, film coated | 90 mg | Anticipated | Available | Manufacturing | 20/02/2025 |
| norethisterone acetate~estradiol~estradiol | Drug delivery system, transdermal | 4.8 mg~.78 mg~.512 mg | Current | Unavailable | Manufacturing | 20/02/2025 |
| spironolactone | Tablet, uncoated | 25 mg | Current | Limited Availability | Manufacturing | 20/02/2025 |
| sitagliptin fumarate | Tablet, film coated | 32.124 mg | Current | Unavailable | Manufacturing | 20/02/2025 |
| alprazolam | Tablet, uncoated | 2 mg | Anticipated | Available | Manufacturing | 20/02/2025 |
| Peginterferon alfa2a | Injection, solution | 135 microgram | Anticipated | Available | Unexpected increase in consumer demand | 20/02/2025 |
| Peginterferon alfa2a | Injection, solution | 180 microgram | Anticipated | Available | Unexpected increase in consumer demand | 20/02/2025 |
| citalopram hydrobromide | Tablet, film coated | 49.96 mg | Current | Limited Availability | Manufacturing | 20/02/2025 |
| methylphenidate hydrochloride | Tablet, modified release | 18 mg | Current | Limited Availability | Manufacturing | 20/02/2025 |
| methylphenidate hydrochloride | Tablet, modified release | 36 mg | Current | Limited Availability | Manufacturing | 20/02/2025 |
| methylphenidate hydrochloride | Tablet, modified release | 54 mg | Current | Limited Availability | Manufacturing | 20/02/2025 |
| sumatriptan succinate | Tablet, film coated | 140 mg | Current | Unavailable | Manufacturing | 19/02/2025 |
| oxytocin | Injection, solution | 5 IU/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 19/02/2025 |
| duloxetine hydrochloride | Capsule, enteric | 67.3 mg | Current | Limited Availability | Manufacturing | 19/02/2025 |
| phenoxymethylpenicillin potassium | Tablet, film coated | 280 mg | Resolved | Available | Manufacturing | 19/02/2025 |
| olmesartan medoxomil~hydrochlorothiazide | Tablet | 40 mg~25 mg | Anticipated | Available | Manufacturing | 19/02/2025 |
| cinacalcet hydrochloride | Tablet | 99.191 mg | Resolved | Available | Manufacturing | 19/02/2025 |
| potassium chloride | Injection, concentrated | 75 mg/mL | Current | Unavailable | Commercial Changes / Commercial viability | 19/02/2025 |
| atorvastatin calcium trihydrate | Tablet, film coated | 86.751 mg | Current | Limited Availability | Manufacturing | 19/02/2025 |
| atorvastatin calcium trihydrate | Tablet, film coated | 43.376 mg | Current | Limited Availability | Manufacturing | 19/02/2025 |
| oxaliplatin | Injection, concentrated | 100 mg | Resolved | Available | Manufacturing | 19/02/2025 |
| nitrofurantoin | Capsule, hard | 100 mg | Anticipated | Available | Manufacturing | 19/02/2025 |
| tamoxifen citrate | Tablet, uncoated | 15.2 mg | Current | Limited Availability | Manufacturing | 19/02/2025 |
| doxycycline hyclate | Tablet, film coated | 57.5 mg | Resolved | Available | Manufacturing | 19/02/2025 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Current | Unavailable | Manufacturing | 19/02/2025 |
| bupivacaine hydrochloride | Injection, solution | 5 mg/mL | Resolved | Available | Manufacturing | 18/02/2025 |
| fluorouracil | Injection, solution | 5000 mg | Current | Unavailable | Unexpected increase in consumer demand | 18/02/2025 |
| donepezil hydrochloride | Tablet, film coated | 5 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 18/02/2025 |
| amlodipine besilate | Tablet | 6.93 mg | Resolved | Available | Manufacturing | 18/02/2025 |
| cisatracurium besilate | Injection, solution | 14.07 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 18/02/2025 |
| isotretinoin | Capsule, soft | 10 mg | Current | Unavailable | Manufacturing | 18/02/2025 |
| ezetimibe | Tablet, uncoated | 10 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 18/02/2025 |
| ivabradine hydrochloride | Tablet, film coated | 8.085 mg | Anticipated | Available | Manufacturing | 18/02/2025 |
| ivabradine hydrochloride | Tablet, film coated | 5.39 mg | Anticipated | Available | Manufacturing | 18/02/2025 |
| fluorouracil | Injection, solution | 50 mg/mL | Current | Unavailable | Manufacturing | 18/02/2025 |
| fluorouracil | Injection, solution | 50 mg/mL | Current | Unavailable | Manufacturing | 18/02/2025 |
| fluorouracil | Injection, solution | 50 mg/mL | Current | Unavailable | Manufacturing | 18/02/2025 |
| amlodipine besilate~olmesartan medoxomil~hydrochlorothiazide | Tablet, film coated | 6.95 mg~40 mg~12.5 mg | Anticipated | Available | Manufacturing | 18/02/2025 |
| tenofovir disoproxil succinate~emtricitabine | Tablet, film coated | 300.6 mg~200 mg | Current | Unavailable | Manufacturing | 18/02/2025 |
| mycophenolate sodium | Tablet, enteric coated | 384.7 mg | Resolved | Available | Manufacturing | 18/02/2025 |
| lamotrigine | Tablet, chewable | 200 mg | Current | Limited Availability | Unexpected increase in consumer demand | 18/02/2025 |
| deferasirox | Tablet, film coated | 360 mg | Current | Unavailable | Manufacturing | 18/02/2025 |
| levothyroxine sodium | Tablet, uncoated | .2 mg | Resolved | Available | Manufacturing | 18/02/2025 |
| fluorouracil | Injection, solution | 50 mg/mL | Current | Limited Availability | Manufacturing | 18/02/2025 |
| norethisterone~ethinylestradiol | Tablet, uncoated | 500 microgram~36 microgram | Current | Limited Availability | Unexpected increase in consumer demand | 18/02/2025 |
| fluorouracil | Injection, solution | 50 mg/mL | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 18/02/2025 |
| adrenaline (epinephrine) acid tartrate | Injection, solution | 1.82 mg/mL | Current | Unavailable | Manufacturing | 17/02/2025 |
| trihexyphenidyl (benzhexol) hydrochloride | Tablet, uncoated | 5 mg | Current | Limited Availability | Unexpected increase in consumer demand | 17/02/2025 |
| metronidazole | Tablet, uncoated | 400 mg | Anticipated | Available | Manufacturing | 17/02/2025 |
| galantamine hydrobromide | Capsule, modified release | 20.504 mg | Current | Unavailable | Manufacturing | 17/02/2025 |
| montelukast sodium | Tablet, chewable | 4.16 mg | Anticipated | Available | Manufacturing | 17/02/2025 |
| montelukast sodium | Tablet, chewable | 4.16 mg | Anticipated | Available | Manufacturing | 17/02/2025 |
| bicalutamide | Tablet, film coated | 50 mg | Current | Unavailable | Manufacturing | 17/02/2025 |
| quetiapine fumarate | Tablet, modified release | 172.695 mg | Anticipated | Available | Unexpected increase in consumer demand | 17/02/2025 |
| quetiapine fumarate | Tablet, film coated | 28.78 mg | Resolved | Available | Manufacturing | 17/02/2025 |
| candesartan cilexetil | Tablet, uncoated | 4 mg | Current | Limited Availability | Manufacturing | 17/02/2025 |
| escitalopram oxalate | Tablet, film coated | 25.47 mg | Current | Limited Availability | Manufacturing | 17/02/2025 |
| clopidogrel besilate | Tablet, film coated | 112.1 mg | Current | Unavailable | Manufacturing | 17/02/2025 |
| simvastatin | Tablet, film coated | 10 mg | Resolved | Available | Manufacturing | 17/02/2025 |
| simvastatin | Tablet, film coated | 80 mg | Current | Unavailable | Manufacturing | 17/02/2025 |
| morphine hydrochloride trihydrate | Injection, solution | 20 mg/mL | Current | Limited Availability | Manufacturing | 17/02/2025 |
| tadalafil | Tablet, film coated | 20 mg | Resolved | Available | Manufacturing | 17/02/2025 |
| ribociclib succinate | Tablet, film coated | 254.4 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 17/02/2025 |
| lacosamide | Tablet, film coated | 100 mg | Anticipated | Available | Unexpected increase in consumer demand | 17/02/2025 |
| pregabalin | Capsule, hard | 75 mg | Resolved | Available | Unexpected increase in consumer demand | 17/02/2025 |
| famotidine | Tablet, film coated | 40 mg | Current | Unavailable | Manufacturing | 17/02/2025 |
2025年2月25日